The role of lipid order and charge in protecting killer T cells from suicide
The role of lipid order and charge in protecting killer T cells from suicide
批准号:
2261561
负责人:
金额:
$0.0万
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --
中文摘要
我们的免疫系统有各种各样的武器可以杀死入侵的病原体和流氓细胞。一个关键的武器是杀伤T细胞(也称为细胞毒性T淋巴细胞),它是一种白细胞,可以清除体内受病毒感染的细胞和癌细胞。也可以从患者身上提取杀伤T细胞,并以所谓的CAR-T细胞的形式重新设计,以更有效地针对肿瘤,最近导致了癌症免疫疗法的一些最引人注目的成功。尽管杀伤T细胞的医学相关性是明确的,但关于它们的功能仍然存在重要的科学问题。众所周知,他们通过首先通过自组装一种名为穿孔素的穿孔蛋白来杀死他们的目标细胞膜,这在一定程度上是我们在Peter MacCallum癌症中心(墨尔本)的广泛工作以及我们自己与他们合作的工作(Leung,Hodel等人,NAT Nanotechnol 2017)。下一步,他们注入其他诱导目标细胞触发程序性细胞死亡(也称为细胞凋亡)的蛋白质。然而,有趣的是,这种有毒的蛋白质组合的作用是单向的。也就是说,杀伤T细胞暴露在它们分泌的有毒蛋白质中,但在与靶细胞的接触中毫发无损,并能够连续杀死多个靶细胞。过去几年,通过在伦敦和墨尔本进行的纳米级生物物理和细胞生物学实验,我们发现,杀伤T细胞通过其膜的物理性质来保护其免受膜穿孔的影响。具体地说,我们发现更有序的脂质排列大大减少了穿孔素与T细胞膜的结合;此外,膜上负电荷的局部暴露破坏了穿孔素孔的形成(Rudd-Schmidt,Hodel等人提交)。与大多数令人兴奋的科学一样,这一发现带来了新的问题,我们的目标是通过这个博士项目来追求。特别是,我们将寻求了解杀伤T细胞将更有序和带电的区域定向到与目标细胞的免疫突触的机制。这个方向意味着在T细胞膜上分离成不同的流体脂质相,这些相更多/更少地有序和带电。为了回答这个问题,我们将在重建的模型膜和活的T细胞上进行纳米尺度的成像实验/分析(原子力显微镜和超分辨率荧光显微镜),并通过发展和使用先进的图像分析(用于超分辨率显微镜数据)和流体膜相局部钉扎的理论模型来解释我们的结果。
英文摘要
Our immune system has a wide range of weapons to kill invading pathogens and rogue cells. A key weapon is that of killer T cells (also called cytotoxic T lymphocytes), which are white blood cells that eliminate virus- infected and cancerous cells in our body. Killer T cells can also be extracted from patients and re-engineered in the form of so-called CAR-T cells to more effectively target tumours, having recently led to some of the most spectacular successes in cancer immunotherapy.While the medical relevance of killer T cells is unambiguous, important scientific questions remain about their function. They are known to kill their targets by first perforating the target cell membrane by self-assembly of a pore-forming protein called perforin, as established in part by extensive work of our collaborators in the Peter MacCallum Cancer Centre (Melbourne) and by our own work in collaboration with them (Leung, Hodel et al., Nat Nanotechnol 2017). Next, they inject other proteins that induce the target cells to trigger programmed cell death (also known as apoptosis). Intriguingly, however, the action of this toxic combination of proteins is unidirectional. That is, killer T cells are exposed to the toxic proteins they secrete and yet survive their encounters with target cells unscathed, and are capable to kill multiple target cells in succession.By joined nanoscale biophysics and cell biology experiments in London and Melbourne over the past years, we have discovered that killer T cells are protected against membrane perforation by the physical properties of their membranes. Specifically, we have found that more ordered lipid arrangements greatly reduce perforin binding to the T cell membranes; in addition, the local exposure of negative charge on the membrane disrupts perforin pore formation (Rudd-Schmidt, Hodel et al., submitted).As with most exciting science, this discovery leads to new questions that we aim to pursue with this PhD project. In particular, we will seek to understand the mechanisms by which killer T cells direct more ordered and charged domains to the immune synapse with the target cell. This direction implies a separation in the T cell membrane into different fluid lipid phases that are more/less ordered and charged. Physically, the intriguing question is how this phase separation is maintained and directed in spite of the noted fluidity of the membrane.To answer this question, we will carry out a combination of nanoscale imaging experiments/ analysis (atomic force microscopy and superresolution fluorescence microscopy) on reconstituted model membranes and live T cells, and interpret our results by developing and using advanced image analysis (for the superresolution microscopy data) and theoretical modelling of local pinning of fluid membrane phases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
脂滴聚集型小胶质细胞介导的髓鞘病变促进小鼠抑郁样行为及其机制研究
-
批准号:82371528
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李媛
-
依托单位:
DACH1对糖尿病肾病足细胞脂质代谢的调控作用和机制研究
-
批准号:82370719
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:曹爱丽
-
依托单位:
新肿瘤靶标 DHCR24/Lipid-Rafts 轴在急性髓系白血病中的作用和分子机制研究
-
批准号:LQ22H080007
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:吴照星
-
依托单位:
4-胺基阿拉伯糖基修饰的活性寡糖分子lipid A及衍生物的合成研究
-
批准号:22007080
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:朱玉根
-
依托单位:
CRISPR/Cas9基因编辑 PLGA/Lipid纳米可视递送系统靶向治疗骨关节炎的作用机制研究
-
批准号:2020A151501615
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2020
-
负责人:于博
-
依托单位:
环状RNA circ-PRKAA1调控肝癌细胞脂代谢重编程的研究
-
批准号:32000527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:李启东
-
依托单位:
脂滴与线粒体的互作在巨噬细胞和动脉粥样硬化中的作用及机制研究
-
批准号:32000482
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:魏园园
-
依托单位:
CRISPR/Cas9基因编辑PLGA/Lipid纳米可视递送系统靶向治疗骨关节炎的作用机制研究
-
批准号:81974323
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:于博
-
依托单位:
STX18介导的脂滴融合与脂滴自噬的机制与功能研究
-
批准号:91957204
-
项目类别:重大研究计划
-
资助金额:330.0万元
-
批准年份:2019
-
负责人:钟清
-
依托单位:
细胞器互作介导磷脂PS转运的功能与调控机制研究
-
批准号:91954207
-
项目类别:重大研究计划
-
资助金额:296.0万元
-
批准年份:2019
-
负责人:黄勋
-
依托单位: